Cargando…

The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia

INTRODUCTION: Community acquired pneumonia (CAP) is a prevalent low respiratory infection. Diagnosis is based on clinical symptoms, radiologic evidence and culture. Biomarkers such as IL6, CRP and procalcitonin are helpful in diagnosis. Procalcitonin is a soluble biomarker in serum that increase in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nikzad, Mahsa, Banafshe, Hamid Reza, Momen-Heravi, Mansooreh, Haddad Kashani, Hamed, Shiehmorteza, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927370/ https://www.ncbi.nlm.nih.gov/pubmed/33658036 http://dx.doi.org/10.1186/s12948-021-00140-1

Ejemplares similares

Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD
por: Çolak, Ayfer, et al.
Publicado: (2017)

Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022)

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia
por: Andrijevic, Ilija, et al.
Publicado: (2014)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia
por: Keramat, Fariba, et al.
Publicado: (2018)

The effects of vitamin D and omega-3 fatty acids co-supplementation on biomarkers of inflammation, oxidative stress and pregnancy outcomes in patients with gestational diabetes
por: Razavi, Maryamalsadat, et al.
Publicado: (2017)

Usefulness of Plasma Procalcitonin to Predict Severity in Elderly Patients with Community-Acquired Pneumonia
por: Kim, Ji Hye, et al.
Publicado: (2013)

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

Biomarkers in Pneumonia—Beyond Procalcitonin
por: Karakioulaki, Meropi, et al.
Publicado: (2019)

Coenzyme Q(10) Administration in Community-Acquired Pneumonia in the Elderly
por: Farazi, Aliasghar, et al.
Publicado: (2014)

The Effects of Vitamin D Supplementation on Signaling Pathway of Inflammation and Oxidative Stress in Diabetic Hemodialysis: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Haddad Kashani, Hamed, et al.
Publicado: (2018)

Value of procalcitonin as a biomarker for postoperative hospital-acquired pneumonia after abdominal surgery
por: Abu Elyazed, Mohamed M, et al.
Publicado: (2017)

Effect of Vitamin D Supplementation on Procalcitonin as Prognostic Biomarker in Patients with Ventilator Associated Pneumonia Complicated with Vitamin D Deficiency
por: Miroliaee, Amir Ebrahim, et al.
Publicado: (2017)

Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia
por: Cohen, Jérémie F., et al.
Publicado: (2012)

Procalcitonin Accurately Identifies Hospitalized Children With Low Risk of Bacterial Community-Acquired Pneumonia
por: Stockmann, Chris, et al.
Publicado: (2018)

The correlation between IgM and IgG antibodies with blood profile in patients infected with severe acute respiratory syndrome coronavirus
por: Alibolandi, Zahra, et al.
Publicado: (2022)

Prevalence of Hepatitis B Surface Antigen in Pregnant Women in Beheshti Hospital of Kashan, Isfahan
por: Afzali, Hasan, et al.
Publicado: (2015)

Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital-acquired pneumonia
por: Wang, Wenlong, et al.
Publicado: (2020)

Epidemiological Distribution and Genotype Characterization of the Hepatitis C Virus Among HIV Patients in Kashan, Iran
por: Afzali, Hasan, et al.
Publicado: (2016)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

Correlation between plasma peroxides and procalcitonin levels in patients with severe streptococcal community acquired pneumonia
por: Borrelli, E, et al.
Publicado: (2002)

Role of C-Reactive Protein and Procalcitonin in Differentiation of Tuberculosis from Bacterial Community Acquired Pneumonia
por: Kang, Young Ae, et al.
Publicado: (2009)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Diagnostic and Prognostic Values of Admission Procalcitonin Levels in Community–Acquired Pneumonia in an Intensive Care Unit
por: Boussekey, N., et al.
Publicado: (2005)

The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia
por: Gilbert, David, et al.
Publicado: (2016)

Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
por: Schuetz, Philipp
Publicado: (2020)

Diagnostic and Prognostic Roles of Procalcitonin and Other Tools in Community-Acquired Pneumonia: A Narrative Review
por: Ozbay, Sedat, et al.
Publicado: (2023)

Biomarkers in Pediatric Community-Acquired Pneumonia
por: Principi, Nicola, et al.
Publicado: (2017)

Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD
por: Bafadhel, Mona, et al.
Publicado: (2011)

Expression of galectin-8 on human endometrium: Molecular and cellular aspects
por: Nikzad, Hossein, et al.
Publicado: (2013)

Can we recognize severe community-acquired pneumonia without pneumonia severity index? Use of modified qSOFA with procalcitonin
por: Güleç, Tolgahan, et al.
Publicado: (2023)

COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia
por: Erami, Mahzad, et al.
Publicado: (2022)

1336. Impact of Procalcitonin-Guided Antibiotic Management in Chronic Obstructive Pulmonary Disease Exacerbation and Community-Acquired Pneumonia
por: Triner, Molly, et al.
Publicado: (2019)

Does procalcitonin have clinical utility in the management of paediatric community-acquired pneumonia? A PRO/CON debate
por: Chiotos, Kathleen, et al.
Publicado: (2021)

Vitamin D Level and Risk of Community-Acquired Pneumonia and Sepsis
por: Jovanovich, Anna J., et al.
Publicado: (2014)

99. Comparison of Procalcitonin Testing to a Targeted Audit-and Feedback Strategy on Prescribed Durations of Therapy for Community-Acquired Pneumonia
por: Clark, Lauren, et al.
Publicado: (2020)

Heparin-binding protein and procalcitonin in the diagnosis of pathogens causing community-acquired pneumonia in adult patients: a retrospective study
por: Cai, Rentian, et al.
Publicado: (2021)

Can Procalcitonin Add to the Prognostic Power of the Severity Scoring System in Adults with Pneumonia?
por: Naderi, HamidReza, et al.
Publicado: (2015)

Prognostic assessment in community-acquired pneumonia by pneumonia severity scores and biomarkers
por: Dusemund, F, et al.
Publicado: (2010)

Biomarkers and clinical scoring systems in community-acquired pneumonia
por: Karakioulaki, Meropi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mcd1mlj1bdequetavna6npgogu